Literature DB >> 10463842

The role of spleen in suppressing the rheological alterations in circulating blood.

O K Baskurt1.   

Abstract

The role of spleen in maintaining the normal rheological properties of red blood cells (RBC) has been investigated by comparing the time course of RBC deformability assessed by the cell transit analyzer (CTA), after the induction of RBC mechanical alterations, in splenectomized and normal guinea pigs. After the exchange transfusions with glutaraldehyde treated (hardened) RBC, most of these cells were removed from the circulation in the splenectomized animals as well as the animals with intact spleens. However, the CTA could detect the longer existence of a small population of hardened RBC in circulation in the splenectomized animals. Measurement of RBC transit times after the onset of experimental sepsis (cecal ligature-puncture) revealed that, in the splenectomized guinea pigs RBC deformability impairment started earlier, in comparison with the animals with intact spleens. These results suggest that the spleen plays an important role in maintaining the normal rheological properties of the circulating blood, especially in the presence of pathophysiological processes affecting RBC mechanics.

Entities:  

Mesh:

Year:  1999        PMID: 10463842

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  3 in total

Review 1.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

2.  In vitro quality control analysis after processing and during storage of feline packed red blood cells units.

Authors:  C Blasi Brugué; Rui R F Ferreira; I Mesa Sanchez; Rita M C Graça; Inês M Cardoso; Augusto J F de Matos; Rafael Ruiz de Gopegui
Journal:  BMC Vet Res       Date:  2018-04-27       Impact factor: 2.741

Review 3.  Drug-loaded erythrocytes: on the road toward marketing approval.

Authors:  Vanessa Bourgeaux; José M Lanao; Bridget E Bax; Yann Godfrin
Journal:  Drug Des Devel Ther       Date:  2016-02-11       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.